Plain-English translation of NCT06860945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand which people taking HIV prevention medication (called PrEP) are more likely to develop sexually transmitted infections. By following 9,000 people across 23 hospitals in Spain, they'll collect health information over time to build a predictive model—essentially a tool that can help doctors identify who needs extra support or monitoring.
People taking this medication are protected from HIV, but they may still be at risk for other sexually transmitted infections. This study aims to find patterns that help doctors predict and prevent these infections before they happen.
You likely qualify if…
You likely don't qualify if…
You'll visit your clinic every three months as part of your regular PrEP monitoring. At each visit, the doctor will collect samples (blood, throat swab, urine, rectal swab, or other samples depending on your needs) to test for sexually transmitted infections. The study uses information already gathered during your normal care—no extra visits or procedures are required beyond standard checkups.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Spain